Characterization of patients with malignant neoplasms of the parotid gland treated at the 'Celia Sánchez Manduley' Hospital

Autor: Carmen Eilyn Rivero-Granado, Irenia Meili León-Céspedes, Elizabeth Vázquez-Blanco, Esperanza Valerino-Guzmán, Héctor Jorge Vázquez-Ortíz

Publikováno v: Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta, Vol 47, Iss 3, Pp e3085-e3085 (2022)

Background: salivary gland tumors are rare lesions. The parotid gland is the most frequent site of these neoplasms, most of which are benign. Objective: to describe clinical and epidemiological variables in patients with malignant neoplasms of the p

Externí odkaz: https://doaj.org/article/55254a42b36449bb902e8bd89fa88308

Calidad de vida de la población adulta con acúfenos.

Autor: Vigliano, M., Romero Orellano , F., Romero Moroni , F.

Publikováno v: Revista Methodo, Vol 1, Iss 1 (2016)

El acúfeno es la percepción de un sonido en ausencia de un estímulo acústico externo. Se estima que comprometen gravemente la calidad de vida de los adultos y se asocia con un deterioro significativo en el desempeño de las actividades cotidianas

Externí odkaz: https://doaj.org/article/95ac94449d544d688e12d47e9ce19162

Papiloma laríngeo en pacientes con carcinoma laríngeo del servicio de otorrinolaringología del Hospital Almenara en el año 2016 y 2017

Autor: Cabrera Cruzado, César Augusto

Publikováno v: REPOSITORIO ACADÉMICO USMP
Universidad de San Martín de Porres – USMP
USMP-Institucional
Universidad de San Martín de Porres
instacron:USMP

Objetivo General: Conocer la frecuencia de pacientes con diagnóstico de papiloma laríngeo previo o concomitante en pacientes con el diagnóstico de carcinoma laríngeo del Servicio de Otorrinolaringología del Hospital Nacional Guillermo Almenara I

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::4cc74efecbd86bca672ddd76aab09690

Otolaryngologic approach to granulomatosis withpolyangitis (Wegener’s)

Autor: Herrera Ariza, Jorge Luis Alfredo, Vllamor Rojas, Perla

Publikováno v: Repositorio Digital Institucional ReDi
Fundación Universitaria de Ciencias de la Salud-FUCS
instacron:Fundación Universitaria de Ciencias de la Salud-FUCS

Introducción: La granulomatosis con poliangeítis (de Wegener) es una enfermedad poco frecuente, sin embargo, el 80 a 90% de los casos tienen manifestaciones otorrinolaringológicas, muchas como único síntoma inicial de la enfermedad. Objetivos: E

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f5a9d4b1b5dab01e12e4a50ed3fd6920
https://repositorio.fucsalud.edu.co/handle/001/1689

Diferencia en calidad de vida en pacientes con rinitis alérgica con beclometasona vs furoato de mometasona y fluticasona

Autor: Reyes Gelves, Camilo, Ballesteros Rodríguez, Lilian

Publikováno v: Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63 Suppl 86:8–160. doi:10.1111/j.1398-9995.2007.01620.x.
Dennis RJ, Caraballo L, García E, et al. Prevalence of asthma and other allergic conditions in Colombia 2009-2010: a cross-sectional study. BMC Pulm Med. 2012;12:17. doi:10.1186/1471-2466-12-17.
Mygind N, Andersson M. Topical glucocorticosteroids in rhinitis: clinical aspects. Acta Otolaryngol. 2006;126(10):1022–1029. doi:10.1080/00016480600672550.
Mullol J, Obando A, Pujols L, Alobid I. Corticosteroid treatment in chronic rhinosinusitis: the possibilities and the limits. Immunol Allergy Clin North Am. 2009;29(4):657–668. doi:10.1016/j.iac.2009.07.001.
Aït-Khaled N, Pearce N, Anderson HR, et al. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy. 2009;64(1):123–148. doi:10.1111/j.1398-9995.2008.01884.x.
Rabe KF, Adachi M, Lai CKW, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol. 2004;114(1):40–47. doi:10.1016/j.jaci.2004.04.042
Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(2 Suppl):S1–84. doi:10.1016/j.jaci.2008.06.003.
Valero A, Baró E, Sastre J, et al. Reference values for facilitating the interpretation of the ESPRINT-15 questionnaire (Spanish version). J Investig Allergol Clin Immunol. 2009;19(5):396–403.
Martínez C, Sossa M, Lemos E. Cost-Effectiveness Analysis of Mometasone Furoate Versus Beclomethasone Dipropionate for the Treatment of Pediatric Allergic Rhinitis in Colombia. Adv Ther 2015; 32:254–269.
Berger W, Meltzer E. Intranasal spray medications for maintenance therapy of allergic rhinitis. Am J Rhinol Allergy 2015; 29: 273-282.
Berlucchi M, Pedruzzi B. Intranasal Mometasone Furoate for Treatment of Allergic Rhinitis. Clinical Medicine Insights: Therapeutics 2010:2 761–769
Yonezaki M, Akiyama K, Karaki M, Goto R, et. all. Preference evaluation and perceived sensory comparison of fluticasone furoate and mometasone furoate intranasal sprays in allergic rhinitis. Auris Nasus Larynx 2015.
Penagos M, Compalati M, Tarantini F, et.all. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials. Allergy 2008: 63: 1280–1291.
Meltzer E, Jacobs E, LaForce C, Kelle L, et.all. Safety and efficacy of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with perennial allergic rhinitis. Allergy Asthma Proc 2012; 33:249 –257.
Farid R, Farid F, Ghaffari J, Jabbarri F. Evaluation of fluticasone nasal spray vs Beclometasona nasal spray in the treatment of allergic rhinitis. Iranian journal of allergy, asthma and inmunology. 2003; 2: 193-196.
Jaruvongvanich V, Mongkolpathumrat P, Chantaphakul H, Klaewsongkram J. Extranasal symptoms of allergic rhinitis are difficult to treat and affect quality of life. 2015; 1-5.
Blaiss MS, Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis. Allergic asma proc. 2011 Nov-Dec;32(6):413-8.
Berger, W; Jacobs R; Amar N ; Sudeesh K, et all. Efficacy and safety of beclomethasone dipropionate nasal aerosol in children with perennial allergic rhinitis. Ann Allergy Asthma Immunol 115 (2015) 130-136.
Crawford1 B, Stanford R, Wong A, Dalal A, Bayliss M. Psychometric validation of the experience with allergic rhinitis nasal spray questionnaire. Patient Related Outcome Measures 2011:2 127–133
Piotr K; Wojciech; J, Spencer K, Katarina Z. Comparative safety and efficacy of two formulations of mometasone nasal spray in adult seasonal allergic rhinitis. Allergy and asthma procedingns 2014, Volume 35, Number 4: 332-337(6)
Davies R, Nelson H. Once-Daily Mometasone Furoate Nasal Spray: Efficacy and Safety of a New Intranasal Glucocorticoid for Allergic Rhinitis. Clinical therapeutics. 1997; 19: 27-38
Hebert JR, Nolop K, Lutsky B. Once daily mometasone furoate aqueous nasal spray (Nasonex) in seasonal allergic rhinitis: An active-and placebo-controlled study. Allergy. 1996;51:569-576
Drouin M, Yang WH, Bertrand B, et al. Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for perennial allergic rhinitis patients. Ann Allergy Asthma Zmmunol. 1996:77:153-160.
Sharpe M, Jarvis B. Inhaled mometasone furoate: A review of its use in adults and adolescents with persistent asthma [published correction appears in Drugs. 2001;61:1325– 1350
Lipworth BJ, Jackson CM. Safety of inhaled and intranasal corticosteroids: Lessons for the new millennium. Drug Saf. 2000;23:11–33.
Davies RJ, Nelson HS. Once-daily mometasone furoate nasal spray: Efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis. Clin Ther. 1997;19:27–38; discussion 2–3.
Frieri M, Therattil J, Chavarria V, et al. Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 1998;81:431–437.
Trangsrud AJ, Whitaker AL, Small RE. Intranasal corticosteroids for allergic rhinitis. Pharmacotherapy. 2002;22:1458– 1467.
Gawchik S, Goldstein S, Prenner B, John A. Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray. Ann Allergy Asthma Immunol. 2003;90:416–421.
Austin RJ, Maschera B, Walker A, et al. Mometasone furoate is a less specific glucocorticoid than fluticasone propionate. Eur Respir J. 2002; 20:1386–1392.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario

Introducción: La rinitis alérgica es una condición común en gran parte de la población en general. Afecta aproximadamente al 32% de la población en general. Materiales y métodos: Estudio prospectivo en cohorte con un diagnóstico clínico de r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eedd1cec49d34c59de2c86c64d77d21
http://repository.urosario.edu.co/handle/10336/12924